NCT01893151 - Effectiveness of Iguratimod Versus Placebo to Treat Early Rheumatoid Arthritis on MRI | Biotech Hunter

Enrollment

200

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Rheumatoid Arthritis

Interventions

DRUG

Iguratimod

Iguratimod placebo:25 mg/tablet, taken orally, 2 tablets/day (bid),52week

DRUG

Iguratimod placebo

Iguratimod placebo:25 mg/tablet, taken orally, 2 tablets/day (bid),24week; Iguratimod:25 mg/tablet, taken orally, 2 tablets/day (bid),28week.

Trial Locations (1)

RECRUITING

Third Affiliated Hospital Of Sun Yat-sen University, Guangzhou